Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ryder

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Contemporary Clinical Trials|January 14, 2024
SMART use of medications for the treatment of adolescent severe obesity: A sequential multiple assignment randomized trial protocolClaudia K Fox, David M Vock, Nancy E Sherwood, et al.
Journal of the American Heart Association|December 29, 2020
Relationship of Circulating Endothelial Cells With Obesity and Cardiometabolic Risk Factors in Children and AdolescentsErica G Soltero, Anna N Solovey, Robert P Hebbel, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 28, 2026
Long-term study retention of adolescents undergoing metabolic and bariatric surgery: lessons learned from the Teen-Longitudinal Assessment of Bariatric Surgery cohortJohn B Rode, Sarah B Ogle, Jane C Khoury, et al.
Obesity (Silver Spring, Md.)|November 4, 2016
Meal replacements followed by topiramate for the treatment of adolescent severe obesity: A pilot randomized controlled trialClaudia K Fox, Alexander M Kaizer, Kyle D Rudser, et al.
JAMA Pediatrics|June 17, 2024
Financial Incentives and Treatment Outcomes in Adolescents With Severe Obesity: A Randomized Clinical TrialAmy C Gross, Rebecca L Freese, Megan O Bensignor, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2013
2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitorsAdam Golebiowski, R Paul Beckett, Michael Van Zandt, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Pediatrics|November 21, 2019
Musculoskeletal Pain, Physical Function, and Quality of Life After Bariatric SurgerySharon Bout-Tabaku, Resmi Gupta, Todd M Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
International Journal of Obesity (2005)|October 11, 2019
Prediction of adult class II/III obesity from childhood BMI: the i3C consortiumJessica G Woo, Nanhua Zhang, Matthew Fenchel, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Contemporary Clinical Trials|January 14, 2024
SMART use of medications for the treatment of adolescent severe obesity: A sequential multiple assignment randomized trial protocolClaudia K Fox, David M Vock, Nancy E Sherwood, et al.
Journal of the American Heart Association|December 29, 2020
Relationship of Circulating Endothelial Cells With Obesity and Cardiometabolic Risk Factors in Children and AdolescentsErica G Soltero, Anna N Solovey, Robert P Hebbel, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 28, 2026
Long-term study retention of adolescents undergoing metabolic and bariatric surgery: lessons learned from the Teen-Longitudinal Assessment of Bariatric Surgery cohortJohn B Rode, Sarah B Ogle, Jane C Khoury, et al.
Obesity (Silver Spring, Md.)|November 4, 2016
Meal replacements followed by topiramate for the treatment of adolescent severe obesity: A pilot randomized controlled trialClaudia K Fox, Alexander M Kaizer, Kyle D Rudser, et al.
JAMA Pediatrics|June 17, 2024
Financial Incentives and Treatment Outcomes in Adolescents With Severe Obesity: A Randomized Clinical TrialAmy C Gross, Rebecca L Freese, Megan O Bensignor, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2013
2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitorsAdam Golebiowski, R Paul Beckett, Michael Van Zandt, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Pediatrics|November 21, 2019
Musculoskeletal Pain, Physical Function, and Quality of Life After Bariatric SurgerySharon Bout-Tabaku, Resmi Gupta, Todd M Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
International Journal of Obesity (2005)|October 11, 2019
Prediction of adult class II/III obesity from childhood BMI: the i3C consortiumJessica G Woo, Nanhua Zhang, Matthew Fenchel, et al.
Pageof 17